TFS
RMD icon

TrustCore Financial Services’s ResMed RMD Stock Holding History

TrustCore Financial Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-37
Closed -$8K – 1132
2022
Q3 		$8K Buy
+37
New +$8.42K ﹤0.01% 794
2020
Q4 		– Sell
-20
Closed -$3K – 945
2020
Q3 		$3K Hold
20
– – ﹤0.01% 747
2020
Q2 		$4K Buy
+20
New +$3.27K ﹤0.01% 742

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

TrustCore Financial Services's RMD Position: Q4 2022 in Review

TrustCore Financial Services sold out of ResMed (RMD) in Q4 2022, closing a stake of 37 shares — an estimated $8K sold.

TrustCore Financial Services first reported a position in RMD in Q2 2020 and held it in 3 quarters. The position peaked at $8K in Q3 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • TrustCore Financial Services reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 37 ResMed shares in Q4 2022, an estimated $8K.
  • TrustCore Financial Services first reported a position in ResMed in Q2 2020 and held it in 3 quarters.
  • TrustCore Financial Services's ResMed position peaked at $8K in Q3 2022.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.